Cizzle Biotechnology Holdings Plc (LON:CIZ)

LON:CIZ Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	0.92	0.88	0.98	0.96	0.85	0.01
Operating Expenses	0.92	0.88	0.98	0.96	0.85	0.01
Operating Income	-0.92	-0.88	-0.98	-0.96	-0.85	-0.01
Other Non Operating Income (Expenses)	0	0.08	-	-	-	-
EBT Excluding Unusual Items	-0.92	-0.8	-0.98	-0.96	-0.85	-0.01
Merger & Restructuring Charges	-	-	-	-	-3.11	-
Gain (Loss) on Sale of Investments	-0.34	-1.39	-0.71	-	-	-
Gain (Loss) on Sale of Assets	-	-	0.04	-	-	-
Other Unusual Items	0.11	-	-0.12	-	-	-
Pretax Income	-1.15	-2.19	-1.76	-0.96	-3.96	-0.01
Income Tax Expense	-0.02	-0.02	-0.05	-0.05	-0.04	-
Net Income	-1.12	-2.17	-1.72	-0.91	-3.92	-0.01
Net Income to Common	-1.12	-2.17	-1.72	-0.91	-3.92	-0.01
Shares Outstanding (Basic)	397	387	356	291	161	0
Shares Outstanding (Diluted)	397	387	356	291	161	0
Shares Change (YoY)	6.83%	8.88%	22.15%	81.49%	32403.47%	57.31%
EPS (Basic)	-0.00	-0.01	-0.00	-0.00	-0.02	-0.03
EPS (Diluted)	-0.00	-0.01	-0.00	-0.00	-0.02	-0.03
EBIT	-0.92	-0.88	-0.98	-0.96	-0.85	-0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.